title: FDA: approval of generic drug reversed by U.S. Court of Appeals.
authors.forename: Sara
authors.initials: S
authors.lastname: Beliveau
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D002140:California; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016503:Drug Delivery Systems; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D016568:Drugs, Generic; D015507:Drugs, Investigational; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D016568:Drugs, Generic; D015507:Drugs, Investigational; D017239:Paclitaxel